Skip to content
Home/Companies/Biotech/Asgard Therapeutics

Asgard Therapeutics

Biotech·Sweden·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Asgard Therapeutics?

Asgard Therapeutics is a Swedish Biotech company, currently owned by Industrifonden since 2021 and 2 other investors.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Boehringer Ingelheim Venture Fund
Most recent investor
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund · 2010 · Evergreen
3 ownership periods · full history below

Key facts

HQSweden
SectorBiotech
StatusActive

Ownership history

3 ownership periods · co-invest detected

Co-invest · 3 holders · 2021 · present
Industrifonden
2021 · present(5yr) · Industrifonden Evergreen · 1991 · VC
Boehringer Ingelheim Venture Fund
2021 · present(5yr) · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
Novo Holdings
2021 · present(5yr) · Novo Holdings Seed Investments · 1999 · VC

Questions

Who owns Asgard Therapeutics?

Asgard Therapeutics is currently owned by Industrifonden, Novo Holdings and 1 other, through Boehringer Ingelheim Venture Fund, since 2021.

When did Industrifonden and 2 others acquire Asgard Therapeutics?

Industrifonden and 2 others acquired Asgard Therapeutics in 2021.

Who has owned Asgard Therapeutics over time?

Asgard Therapeutics has been through 3 private-equity ownership periods: Industrifonden · via Industrifonden Evergreen · since 2021; Novo Holdings · via Novo Holdings Seed Investments · since 2021; Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue